IPM, HIV Treatment

20 Jun 2016

IPM, the International Partnership for Microbiocides, a non-profit organisation supported by charitable donations, have developed a device that prevents the transmission of the HIV virus.  The device is currently in Phase III trials.  The intent is to distribute these in Africa, a continent with high rates of hetrosexual transmission.  The current prototypes are manufactured in Denmark but are expensive.  So the manufacturing process has to be scaled up for launch quantities and the costs reduced sixfold.

STC worked with the manufacturing experts to scale the process, obviously without changing the registered process and to reduce the costs.

In parallel STC conducted a search to identify potential partners who could manufacture the products and also engage in it's distribution.

For further information on this device and its progress through clinical trials - click here

Last Modified: Monday 20 June 2016 11:43

No Comments Yet...

Leave a reply

Your email address will not be published.